IP Library Granted Patent US 7,741,111
Granted Patent B2
US 7,741,111 · App. 11/374,353 · Granted Jun 22, 2010

Pregnancy, up-regulated non-ubiquitous CaM kinase

Assignee: The Trustees of the University of Pennsylvania
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,741,111
App. No.
11/374,353
Granted
Jun 22, 2010
Kind
B2
Abstract

This invention relates generally to a novel CaM multi-functional protein kinase, which has been named Pregnancy Up-Regulated, Nonubiquitous CaM Kinase (PNCK), and to the nucleotide sequence encoding it. The kinase is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers. The invention further relates to an analysis of a correlation between carcinogenesis and postnatal development, particularly mammary development, especially associated with parity; as well as to methods of using the kinase, or gene encoding it, as markers, prognostic tools, screening tools and therapies, in vitro and in vivo that are based upon that correlation.

Claims (18)

1. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID No: 7.

2. An isolated vector comprising the isolated nucleic acid molecule of claim 1 .

3. An isolated nucleic acid molecule comprising a sequence fully complementary to the nucleic acid sequence of claim 1 .

4. An isolated nucleic acid molecule comprising the nucleic acid molecule of claim 1 that is radiolabeled.

5. An isolated vector comprising the isolated nucleic acid molecule of claim 3 .

6. An isolated nucleic acid molecule comprising the nucleic acid molecule of claim 3 that is radiolabeled.

7. An isolated host cell comprising the vector of claim 2 .

8. An isolated host cell comprising the vector of claim 5 .

9. An isolated nucleic acid molecule comprising a fragment of the nucleotide sequence of SEQ ID NO: 7, wherein said fragment consists of a nucleotide sequence encoding at least about 20 amino acids of SEQ ID NO: 8.

10. The isolated nucleic acid molecule of claim 9 , which is radolabeled.

11. An isolated vector comprising the nucleic acid molecule of claim 9 .

12. An isolated host cell comprising the vector of claim 11 .

13. An isolated nucleic acid molecule comprising a nucleotide sequence fully complementary to a fragment of the nucleotide sequence of SEQ ID NO: 7, wherein said fragment consists of a nucleotide sequence encoding at least about 20 amino acids of SEQ ID NO: 8.

14. The isolated nucleic acid molecule of claim 13 , which is radolabeled.

15. An isolated vector comprising the nucleic acid molecule of claim 13 .

16. An isolated host cell comprising the vector of claim 15 .

17. The isolated host cell of any of claims 7 , 8 , 12 , and 13 , which is eukaryotic.

18. The isolated host cell of claim 17 , which is mammalian.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 20, 2023
From: UNIVERSITY OF PENNSYLVANIA
To: UNITED STATES GOVERNMENT
Reel/Frame 065629/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2011
From: CHODOSH, LEWIS A.; GARDNER, HEATHER P.
To: TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 026765/0521 →
Continuity (3)
Continuation 1003225400 · Dec 21, 2001
Provisional Application 6025707300 · Dec 21, 2000
Related Publication 20070259419A1 · Nov 8, 2007